Aytu BioPharma, Inc. (AYTU)
1.81
-0.11
(-5.73%)
USD |
NASDAQ |
Nov 05, 16:00
Aytu BioPharma Price to Book Value : 0.5505 for Nov. 5, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 0.5505 |
| November 04, 2026 | 0.5839 |
| November 03, 2026 | 0.587 |
| November 02, 2026 | 0.59 |
| October 30, 2026 | 0.587 |
| October 29, 2026 | 0.6022 |
| October 28, 2026 | 0.5992 |
| October 27, 2026 | 0.5779 |
| October 26, 2026 | 0.587 |
| October 23, 2026 | 0.5779 |
| October 22, 2026 | 0.6022 |
| October 21, 2026 | 0.5961 |
| October 20, 2026 | 0.6113 |
| October 19, 2026 | 0.5961 |
| October 16, 2026 | 0.6204 |
| October 15, 2026 | 0.6113 |
| October 14, 2026 | 0.5931 |
| October 13, 2026 | 0.6052 |
| October 12, 2026 | 0.5992 |
| October 09, 2026 | 0.6159 |
| October 08, 2026 | 0.6235 |
| October 07, 2026 | 0.6235 |
| October 06, 2026 | 0.6235 |
| October 05, 2026 | 0.6204 |
| October 02, 2026 | 0.6296 |
| Date | Value |
|---|---|
| October 01, 2026 | 0.6357 |
| September 30, 2026 | 0.6509 |
| September 29, 2026 | 0.6691 |
| September 28, 2026 | 0.66 |
| September 25, 2026 | 0.6934 |
| September 24, 2026 | 0.7026 |
| September 23, 2026 | 0.6934 |
| September 22, 2026 | 0.6782 |
| September 21, 2026 | 0.6463 |
| September 18, 2026 | 0.6448 |
| September 17, 2026 | 0.6083 |
| September 16, 2026 | 0.5992 |
| September 15, 2026 | 0.6052 |
| September 14, 2026 | 0.6083 |
| September 11, 2026 | 0.6052 |
| September 10, 2026 | 0.6235 |
| September 09, 2026 | 0.6448 |
| September 08, 2026 | 0.6661 |
| September 04, 2026 | 0.6721 |
| September 03, 2026 | 0.695 |
| September 02, 2026 | 0.6934 |
| September 01, 2026 | 0.6843 |
| August 31, 2026 | 0.6965 |
| August 28, 2026 | 0.6843 |
| August 27, 2026 | 0.6813 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.700 |
| Corcept Therapeutics, Inc. | 9.704 |
| Veru, Inc. | 1.244 |
| Johnson & Johnson | 8.004 |
| Eli Lilly & Co. | 31.92 |
Price to Book Value Related Metrics
| PS Ratio | 0.4665 |
| Price to Free Cash Flow | 8.258 |
| Price | 1.81 |
| Earnings Yield | -92.11% |
| Market Cap | 19.42M |